inhibitor
US /ɪnˈhɪbɪtɚ/
・UK /ɪnˈhɪbɪtə(r)/
B1 中級
n.名詞止氧劑 ； 抑製劑 ； 鎮定劑
This chemical is an inhibitor of digestion
影片字幕
史丹佛奈米製程中心：乾蝕刻－乾蝕刻原理 (第四部分之三) (Stanford Nanofabrication Facility: Dry Etching - Dry Etching Mechanisms (Part 3 of 4))
- Then, ion-enhanced inhibitor etching.
然後是離子增強抑制劑蝕刻。
- And then ion-enhanced inhibitor etching.
然後是離子增強抑制劑蝕刻。
STRONG-HF 結果出爐！ (STRONG-HF Results)
- Then before in the high-intensity arm, before being discharged, he receives half beta-blocker and half ACE, or RAAS inhibitor, and
他帶著結果來，進行看診，然後研究者會根據臨床檢查，看看有沒有水腫，量血壓、心跳，就這麼簡單。
- Then before in the high intensity arm, before being discharged, he receives half beta blocker and half ACE or RICE inhibitor and half spironolactone.
然後在高強度組別裡，出院前，他會拿到半劑量的 beta blocker 和半劑量的 ACE 或 RICE 抑制劑，以及半劑量的 spironolactone。
2025年必學！專家認證的強大技巧，讓你擺脫強迫症！ (Expert-Approved Tips To Take Control of OCD In 2025)
- Most likely, you'll start on an antidepressant, one that we call an SSRI or a serotonin selective reuptake inhibitor, or maybe an SNRI, which are bringing in other neurotransmitters there too, like norepinephrine.
市面上有許多很棒的藥物。
- Most likely you'll start on an antidepressant, one that we call an SSRI or a serotonin selective reuptake inhibitor or maybe an snri, which are bringing in other neurotransmitters there too, like norepinephrine.
大多數情況下，你可能會先從抗憂鬱藥物開始，一種我們稱為 SSRI 或血清素選擇性再回收抑制劑的藥物，或是 SNRI，它也會引入其他神經傳導物質，例如去甲腎上腺素。
NEJM 本週特刊 — 2026 年 1 月 8 日 (NEJM This Week — January 8, 2026)
- Visit nejm.org to vote and to see how others chose Evolocumab in patients without a previous myocardial infarction or stroke By Erin Bahula from Brigham and Women's Hospital, Boston and co authors the proprotein convertase subtilisinquexin type 9 PCSK9 inhibitor evolocumab reduces the risk of major adverse cardiovascular events among patients with a previous myocardial infarction, stroke, or symptomatic peripheral artery disease.
前往 nejm.org 投票，並看看其他人如何選擇 Evolocumab，適用於先前沒有心肌梗塞或中風的患者。作者為波士頓 Brigham and Women's Hospital 的 Erin Bahula 及共同作者，PCSK9 抑制劑 evolocumab 可降低先前有心肌梗塞、中風或有症狀周邊動脈疾病患者的主要不良心血管事件風險。
- The pro-protein convertase subtilisin-kexin type 9 (PCSK9) inhibitor, evolocumab, reduces the risk of major adverse cardiovascular events (MACE) among patients with a previous myocardial infarction, stroke, or symptomatic peripheral artery disease.
超過 12,000 名患有動脈粥狀硬化或糖尿病，且先前沒有心肌梗塞或中風，低密度脂蛋白膽固醇水準至少為 90 mg/dL 的患者，被隨機分配接受 evolocumab 或安慰劑。
我最近做錯了什麼？🤔 (What I’ve Been Doing Wrong Recently.)
- The formula was written as 200 milligrams of who brazine rather than 200 micrograms and for those that don't know a microgram is 1,000 milligrams so I took double that so I took 2,000 times the dose of who brazine and it just smacked me in the face and took me out For hours and it was not a fun experience I guess there's something called parasympathetic rash Because who brazine in a seal choline inhibitor It's supposed to lock you and give you good focus like chill good focus And if it's just too much producing too much signal in your body I just had like a I don't know my nervous system like shut down and overloaded and was just trying to get it out of me because it was like toxic because there's so much honestly lucky that it was a Big enough to handle that and it wasn't more serious because taking 2,000 like think of taking a pill I have these pills or 200 micrograms in my closet I just having 2,000 of those pills and just taking all of the ones Absolutely absurd so we will not be making that product, but the point is This is my weird brain the way it works, but every time something fucked up happens.
配方上寫的是 200 毫克 who brazine，而不是 200 微克，對於那些不知道一微克等於 1,000 毫克的人來說，我服用了雙倍的劑量，所以我服用了 2、所以我吃了兩千倍的who brazine 它就打在我臉上 讓我昏迷了幾個小時 這可不是什麼有趣的經歷 我猜這就是所謂的副交感神經皮疹 因為who brazine是一種膽鹼抑制劑我的神經系統就像關閉了一樣 負荷過重 我只是想把它從我體內弄出來 因為它就像有毒的一樣 因為有太多的東西了 說實話 我很幸運 它足夠大到可以處理這個問題了我的衣櫃裡有20
- I guess there's something called a parasympathetic rash because hubrazine is a sealed choline inhibitor.
讓我們拋棄他們，繼續前進。
降膽固醇新希望？Bempedoic Acid 心血管成效大揭密｜NEJM (Bempedoic Acid and Cardiovascular Outcomes | NEJM)
- A recent trial examined the efficacy and safety of bempedoic acid, an ATP citrate lyase inhibitor, that reduces LDL cholesterol, for preventing cardiovascular events in patients with statin intolerance.
最近的一項試驗研究了貝門冬氨酸的有效性和安全性，貝門冬氨酸是一種 ATP 檸檬酸酶抑制劑，可降低低密度脂蛋白膽固醇，用於預防他汀類藥物不耐受患者的心血管事件。
- A recent trial examined the efficacy and safety of bempedoic acid, an ATP citrate lyase inhibitor, that reduces LDL cholesterol for preventing cardiovascular events in patients with statin intolerance.
最近的一項試驗研究了貝門冬氨酸的有效性和安全性，貝門冬氨酸是一種 ATP 檸檬酸酶抑制劑，可降低低密度脂蛋白膽固醇，用於預防他汀類藥物不耐受患者的心血管事件。